Hepatitis B virus X protein confers resistance of hepatoma cells to anoikis by up-regulating and activating p21-activated kinase 1
about
HBV induced HCC: major risk factors from genetic to molecular levelThe role of p21-activated kinases in hepatocellular carcinoma metastasisKlotho endows hepatoma cells with resistance to anoikis via VEGFR2/PAK1 activation in hepatocellular carcinomaHepatitis B virus infection and active replication promote the formation of vascular invasion in hepatocellular carcinoma.Midkine promotes hepatocellular carcinoma metastasis by elevating anoikis resistance of circulating tumor cells.The virus-induced protein APOBEC3G inhibits anoikis by activation of Akt kinase in pancreatic cancer cells.Republished: tracing PAKs from GI inflammation to cancerPolycomb-mediated loss of microRNA let-7c determines inflammatory macrophage polarization via PAK1-dependent NF-κB pathway.Decreased expression of hepatocyte nuclear factor 4α (Hnf4α)/microRNA-122 (miR-122) axis in hepatitis B virus-associated hepatocellular carcinoma enhances potential oncogenic GALNT10 protein activity.Prognostic importance and therapeutic implications of PAK1, a drugable protein kinase, in gastroesophageal junction adenocarcinoma.Tumor Suppressive Function of p21-activated Kinase 6 in Hepatocellular Carcinomap21-activated kinase 1 determines stem-like phenotype and sunitinib resistance via NF-κB/IL-6 activation in renal cell carcinoma.miRNA-7/21/107 contribute to HBx-induced hepatocellular carcinoma progression through suppression of maspin.HBx sensitizes hepatocellular carcinoma cells to lapatinib by up-regulating ErbB3.DNA-dependent activator of interferon-regulatory factors (DAI) promotes lupus nephritis by activating the calcium pathway.p21-activated kinase 1 (PAK1) expression correlates with prognosis in solid tumors: A systematic review and meta-analysisTracing PAKs from GI inflammation to cancer.Loss of N-Acetylgalactosaminyltransferase-4 Orchestrates Oncogenic MicroRNA-9 in Hepatocellular Carcinoma.Reactive Oxygen Species-Mediated c-Jun NH2-Terminal Kinase Activation Contributes to Hepatitis B Virus X Protein-Induced Autophagy via Regulation of the Beclin-1/Bcl-2 Interaction.Group I p21-activated kinases facilitate Tax-mediated transcriptional activation of the human T-cell leukemia virus type 1 long terminal repeats.Enhancer of zeste homolog 2 (EZH2) promotes tumour cell migration and invasion via epigenetic repression of E-cadherin in renal cell carcinoma.Sunitinib induces cellular senescence via p53/Dec1 activation in renal cell carcinoma cells.Sorafenib suppresses growth and survival of hepatoma cells by accelerating degradation of enhancer of zeste homolog 2.Subverting Host Cell P21-Activated Kinase: A Case of Convergent Evolution across Pathogens.The regulation of proteins associated with the cytoskeleton by hepatitis B virus X protein during hepatocarcinogenesis.Hepatitis B virus X protein promotes hepatoma cell invasion and metastasis by stabilizing Snail protein.Anoikis resistance and oncoviruses.A Novel Pak1/ATF2/miR-132 Signaling Axis Is Involved in the Hematogenous Metastasis of Gastric Cancer Cells.p21-activated kinase 1 predicts recurrence and survival in patients with non-metastatic clear cell renal cell carcinoma.Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018.Applications of next-generation sequencing analysis for the detection of hepatocellular carcinoma-associated hepatitis B virus mutations.
P2860
Q26825274-95431620-527F-452A-A5BA-6A1C491E9903Q27016620-CD476826-B255-4F0F-8F64-269DA81490A2Q28287609-3EF8BFBB-C704-48D3-87A9-3854AEA71DB9Q33630432-9A63D70A-9540-4731-B027-74E1C4F1E260Q33779147-4EFD33D8-72AD-4C22-A231-1CE862EB70AFQ34044486-BF9DE624-A2B2-4260-B47F-5291DEAF90D9Q34463139-F04A2076-60EF-4A4C-8690-250938E6AA9CQ34924167-30518CC2-BA92-42E7-A88F-AA649342A133Q34958488-A570CF11-E618-488D-BACD-3289B64E0DEEQ35043996-B9519A5D-FE6E-4EE6-9779-5A4282A2E9A3Q36301347-DCBF98E5-36CB-4128-9DD3-271215A2263EQ36347284-E3279F03-A7FF-46C0-80E0-17B65283C65FQ36413338-7F708672-2D35-4E30-B639-E2FE8335F184Q36729450-270137A2-ACE9-4533-8339-2BC32BAA7A58Q36832638-27D9347B-966D-409D-85B3-5218B3D8F79AQ37317276-E48FFABB-EF71-48F0-9374-A8D3DFD3BDD9Q38210506-C15283CF-DDC2-498E-9523-D88675EA6E8CQ38722581-638ED074-BDEE-4F1D-A319-FF581FB83A4EQ38780065-E278A1BD-5761-4E35-BB31-F58B6663E86AQ38937779-FA73DB69-F5FD-4080-B45F-7DEE96966687Q39017057-25597EFE-9B7A-4D62-A9C5-A01141FC5150Q39167898-BEB02EE8-181C-436A-AEB3-51A21B37EAD5Q39192075-524AC475-3A65-4D67-8485-83D83BA699F8Q39254514-79D686C7-2149-412C-A04B-EC1655610816Q39270483-F0580C45-8C24-48FD-8EAB-FF8E600F919DQ39283583-01E9BDAC-ECD3-4838-9B2C-F198CA577F60Q40072469-6FBBB73A-84B3-405F-A028-8599B1FB7425Q41191006-95A0A6D2-9D29-48CE-B6E7-906637F71BFEQ46203111-A488E77A-4E55-42EC-BF83-667CF94CCC37Q47843948-6E075E87-D1F3-432B-9214-03231D795FF6Q55395370-6B6F8A68-40F6-419D-9DC9-BBADA1561837
P2860
Hepatitis B virus X protein confers resistance of hepatoma cells to anoikis by up-regulating and activating p21-activated kinase 1
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Hepatitis B virus X protein co ...... ivating p21-activated kinase 1
@ast
Hepatitis B virus X protein co ...... ivating p21-activated kinase 1
@en
Hepatitis B virus X protein co ...... ivating p21-activated kinase 1
@nl
type
label
Hepatitis B virus X protein co ...... ivating p21-activated kinase 1
@ast
Hepatitis B virus X protein co ...... ivating p21-activated kinase 1
@en
Hepatitis B virus X protein co ...... ivating p21-activated kinase 1
@nl
prefLabel
Hepatitis B virus X protein co ...... ivating p21-activated kinase 1
@ast
Hepatitis B virus X protein co ...... ivating p21-activated kinase 1
@en
Hepatitis B virus X protein co ...... ivating p21-activated kinase 1
@nl
P2093
P3181
P1433
P1476
Hepatitis B virus X protein co ...... ivating p21-activated kinase 1
@en
P2093
Jianxin Gu
Linlin Sun
Shanshan Wang
Xiaojing Yun
P304
199-212.e4
P3181
P356
10.1053/J.GASTRO.2012.03.053
P407
P577
2012-07-01T00:00:00Z